Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Stepan Company (SCL) SEC Filings & Earnings Calls

EquiReason read 12 Stepan Company SEC filings in the last 12 months. Latest: 8-K on 2026-09-28 — Stepan Company entered into a new $500M credit agreement ($350M revolver + $150M term loan) maturing 2031, replacing existing $350M revolver and $100M term loan. Includes $250M exp.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SCLStepan CompanyFollow SCL — free
Specialty Chemicals · Basic Materials
—
Price chart with a free account
Market cap
1.5B
P/E TTM
—
Dividend yield
2.5%
52-week
—
Next earnings
28 Oct, in 4 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

28 Sep 20268-K · 1.01, 2.03Stepan Company entered into a new $500M credit agreement ($350M revolver + $150M term loan) maturing 2031, replacing existing $350M revolver and $100M term loan. Includes $250M expansion option.open

Figures in the filing · each found in the filing text

credit_facility_amount · 2026-09-25$500M

Risks flagged

Covenants include interest coverage and net leverage ratios; default events could accelerate repayment.

“Requires maintenance of certain interest coverage and net leverage financial ratios and compliance with certain other covenants.”
Read the original on SEC EDGAR ↗
5 Aug 202610-QStepan Company reported strong Q2 2026 results with revenue up 15% YoY and operating income up 107% YoY, driven by pricing actions and volume growth.earningsopen

Figures in the filing · each found in the filing text

Net Income · Q2-2026$23M+103% y/y
Adjusted Net Income · Q2-2026$27M+126% y/y
Adjusted EBITDA · Q2-2026$74M+45% y/y
Cash and Cash Equivalents · 2026-06-30$114M
Total Debt · 2026-06-30$647M

Risks flagged

Restructuring Execution Risk

“The Company recognized $5.1 million and $70.5 million of pre-tax business restructuring expense related to these asset shutdowns during the second quarter and the first six months of 2026, respectively.” · word for word

Geopolitical and Supply Uncertainty

“The Company believes a portion of the volume growth reflects customer pre-buying in response to geopolitical and product supply uncertainty.” · word for word
Read the original on SEC EDGAR ↗
29 Jul 20268-K · 2.02, 2.05, 5.02, 8.01Q2 2026 net income up 102% YoY to $22.9M; Adjusted EBITDA up 45% to $74.4M. Also announced workforce reduction of ~100 roles as part of restructuring plan.earningsopen

Figures in the filing · each found in the filing text

Net income · Q2-2026$23M+102% y/y
Adjusted EBITDA · Q2-2026$74M+45% y/y
Organic sales volume growth · Q2-20266.0%
Free cash flow (excluding working capital) · Q2-2026$33M+69% y/y

Risks flagged

Restructuring charges of $75-80M for FY2026; cash impact $14-18M.

“The Company anticipates recognizing full-year restructuring charges in the range of $75.0 million to $80.0 million in connection with Project Catalyst.” · word for word

Free cash flow negative $15.0M due to higher working capital requirements.

“Free cash flow for the quarter was a negative $15.0 million, driven by higher working capital requirements.”
Read the original on SEC EDGAR ↗
6 May 202610-QNet Income (Loss) $-41M; Adjusted EBITDA $50M (-14% y/y); Cash and Cash Equivalents $141M; Guidance: FY2026 capex guided $105M-$115M; no revenue or earnings guidance providedopen

Figures in the filing · each found in the filing text

Net Income (Loss) · Q1-2026$-41M
Adjusted EBITDA · Q1-2026$50M-14% y/y
Cash and Cash Equivalents · 2026-03-31$141M

Guidance

FY2026 capex guided $105M-$115M; no revenue or earnings guidance provided

No explicit revenue or earnings guidance; capex guidance maintained; restructuring indicates management is proactively addressing cost structure.

Risks flagged

Restructuring execution risk

“The Company recognized $65.4 million of pre-tax business restructuring expense related to these asset shutdowns during the first quarter of 2026.” · word for word

Competitive pressure in Latin America

“The lower average unit margins largely reflect increased competitive pressures in Mexico.” · word for word

European construction demand weakness

“The lower sales volume is due to lower construction demand related to the macroeconomic environment and economic uncertainties along with increased competitive activity.” · word for word
Read the original on SEC EDGAR ↗
28 Apr 20268-K · 2.02, 8.01Net Sales $605M (+2% y/y); Net Income (Loss) $-41M; Adjusted Net Income $10M (-47% y/y)earningsopen

Figures in the filing · each found in the filing text

Net Sales · Q1-2026$605M+2% y/y
Net Income (Loss) · Q1-2026$-41M
Adjusted Net Income · Q1-2026$10M-47% y/y
Adjusted EBITDA · Q1-2026$50M-14% y/y
Specialty Products Adjusted EBITDA · Specialty Products · Q1-2026$6M-11% y/y

Risks flagged

Restructuring execution risk and potential operational disruptions from site closures.

“We are executing Project Catalyst safely and in line with expectations despite early quarter weather-related impacts and the new geopolitical challenges.” · word for word

Higher oleochemicals raw material costs and competitive pressures in Mexico impacting Surfactants margins.

“Surfactants EBITDA was down due to higher oleochemicals prices, the cold snap in the U.S., production timing differences in Asia along with competitive pressures in Mexico.” · word for word

European Polymers demand weakness persists with 19% volume decline.

“Sales volume decreased 6% in the quarter. North American sales volume was up 5% but this was more than offset by a 19% decline in Europe.” · word for word
Read the original on SEC EDGAR ↗
25 Mar 2026DEF 14AAnnual proxy statement filed, detailing executive compensation, financial results, and governance matters for FY2025.open

Figures in the filing · each found in the filing text

Net Income · FY2025$47M-7% y/y
Adjusted Net Income · FY2025$42M-17% y/y
Diluted EPS · FY2025$2.05-7% y/y
Adjusted Diluted EPS · FY2025$1.82-17% y/y
Surfactants Operating Income · Surfactants · FY2025$67M-21% y/y
Polymers Operating Income · Polymers · FY2025$43M+7% y/y
Specialty Products Operating Income · Specialty Products · FY2025$26M+23% y/y
Dividends Paid · FY2025$35M
EBITDA · FY2025$208M
Free Cash Flow · FY2025$27M

Risks flagged

Surfactant segment earnings decline

“The Surfactant segment delivered operating income of $67.4 million, a 21% decrease versus prior year.” · word for word
Read the original on SEC EDGAR ↗
26 Feb 202610-KRecurring environmental costs $45M; Number of employees 2,328 (-3% y/y)open

Figures in the filing · each found in the filing text

Recurring environmental costs · FY2025$45M
Number of employees · 2025-12-312,328-3% y/y

Risks flagged

Raw material and energy cost volatility

“The volatility of raw material, natural gas and electricity costs, as well as any disruption in their supply, may result in increased costs and materially and adversely affect the Company’s business, financial position, results of operations and cash flows.” · word for word

1,4 dioxane regulatory risk

“These trends and corresponding changes in consumer preferences could reduce demand for our ethoxylated surfactant products, as our customers look to reduce the levels of ethoxylated surfactants in their finished products to stay below the maximum allowed levels or transition to alternative surfactants with lower levels of 1,4 dioxane.” · word for word

Operational disruption from natural disasters

“For example, in 2024, the operations of the Company’s Elwood, Illinois (Millsdale) facility were negatively affected by a flood event.” · word for word

Geopolitical risk affecting supply chain

“For example, recent conflicts in the Middle East region have contributed to increased shipping costs and transportation times for certain raw materials and products.” · word for word
Read the original on SEC EDGAR ↗
23 Feb 20268-K · 2.02, 8.01Net Sales $554M (+5% y/y); Net Income $5M (+49% y/y); Adjusted Net Income $-531,000.00 (-119% y/y)earningsopen

Figures in the filing · each found in the filing text

Net Sales · Q4-2025$554M+5% y/y
Net Income · Q4-2025$5M+49% y/y
Adjusted Net Income · Q4-2025$-531000.00-119% y/y
EBITDA · Q4-2025$43M+21% y/y
Adjusted EBITDA · Q4-2025$34M-3% y/y
Free Cash Flow · Q4-2025$25M
Global Sales Volume Change · Q4-2025-3.0%
Surfactant Net Sales · Surfactants · Q4-2025$402M+6% y/y
Polymers Net Sales · Polymers · Q4-2025$132M+1% y/y
Specialty Products Net Sales · Specialty Products · Q4-2025$20M+20% y/y

Risks flagged

Surfactant volume decline due to lower demand in commodity Laundry & Cleaning end markets indicates consumer demand slowdown.

“Surfactant sales volume declined 7% year-over-year primarily due to lower demand within the commodity Laundry & Cleaning end markets.”

Higher interest expense from lower capitalized interest due to Pasadena site start-up.

“Higher interest expense, resulting from lower capitalized interest income recognition due to the Pasadena, TX site start-up.” · word for word
Read the original on SEC EDGAR ↗
23 Feb 20268-K · 2.05, 7.01Stepan approved Project Catalyst, a restructuring plan to close Fieldsboro site and decommission assets, targeting $100M pre-tax savings over two years with $70-80M charges in 2026.open

Risks flagged

Restructuring execution risk and potential operational disruption from site closures and asset decommissioning.

“Closure of Fieldsboro site and decommissioning of assets at Elwood and Stalybridge facilities by mid-2026.”

Continued demand weakness in commodity surfactants may persist, impacting revenue.

“Site closure driven by continued lower demand in commodity surfactants.”
Read the original on SEC EDGAR ↗
28 Nov 20258-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen

Risks flagged

Severance plan could increase costs in case of executive departures or change in control.

“Cash severance in an amount equal to (i) the sum of the Executive’s base salary plus target annual bonus multiplied by (ii) the number of months in the Severance Period” · word for word
Read the original on SEC EDGAR ↗
5 Nov 202510-QStepan reported Q3 2025 net income down 54% YoY due to surfactant margin compression and higher start-up costs, despite 8% revenue growth.earningsopen

Figures in the filing · each found in the filing text

Net income · Q3-2025$11M-54% y/y
Adjusted net income · Q3-2025$11M-54% y/y
EBITDA · Q3-2025$56M+6% y/y

Guidance

Capital expenditure estimate $118M-$123M for 2025

No explicit earnings guidance provided; capital expenditure estimate maintained for 2025.

Risks flagged

Raw material cost volatility

“The lower average unit margins negatively impacted the year-over-year change in gross profit by $5.7 million and were primarily attributable to higher expenses associated with the start-up of the Company's new alkoxylation facility in Pasadena, Texas and higher oleochemical raw material costs.” · word for word

New facility start-up costs

“higher expenses associated with the start-up of the Company's new alkoxylation facility in Pasadena, Texas” · word for word

Pharmaceutical order timing volatility

“This increase was primarily due to higher sales volume that was driven by order timing fluctuations within the pharmaceutical business.” · word for word
Read the original on SEC EDGAR ↗
29 Oct 20258-K · 8.01Quarterly cash dividend per share $0.40open

Figures in the filing · each found in the filing text

quarterly cash dividend per share · Q4-2025$0.40
Read the original on SEC EDGAR ↗

Stepan Company — questions

What did Stepan Company file recently?
12 SEC filings in the last 12 months. Latest: 8-K on 2026-09-28 — Stepan Company entered into a new $500M credit agreement ($350M revolver + $150M term loan) maturing 2031, replacing existing $350M revolver and $100M term loan. Includes $250M expansion option.

Every figure on this page comes from Stepan Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.